Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 3
2019 2
2020 5
2021 13
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
The Female-Predominant Persistent Immune Dysregulation of the Post-COVID Syndrome.
Ganesh R, Grach SL, Ghosh AK, Bierle DM, Salonen BR, Collins NM, Joshi AY, Boeder ND Jr, Anstine CV, Mueller MR, Wight EC, Croghan IT, Badley AD, Carter RE, Hurt RT. Ganesh R, et al. Mayo Clin Proc. 2022 Mar;97(3):454-464. doi: 10.1016/j.mayocp.2021.11.033. Epub 2022 Feb 5. Mayo Clin Proc. 2022. PMID: 35135695 Free PMC article.
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection.
Puranik A, Lenehan PJ, Silvert E, Niesen MJM, Corchado-Garcia J, O'Horo JC, Virk A, Swift MD, Gordon JE, Speicher LL, Geyer HL, Kremers W, Halamka J, Badley AD, Venkatakrishnan AJ, Soundararajan V. Puranik A, et al. Med. 2022 Jan 14;3(1):28-41.e8. doi: 10.1016/j.medj.2021.12.002. Epub 2021 Dec 11. Med. 2022. PMID: 34927113 Free PMC article.
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19.
Ganesh R, Pawlowski CF, O'Horo JC, Arndt LL, Arndt RF, Bell SJ, Bierle DM, Borgen MD, Hanson SN, Heyliger A, Larsen JJ, Lenehan PJ, Orenstein R, Puranik A, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Razonable RR. Ganesh R, et al. J Clin Invest. 2021 Oct 1;131(19):e151697. doi: 10.1172/JCI151697. J Clin Invest. 2021. PMID: 34411003 Free PMC article.
Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response.
Chavan S, Mangalaparthi KK, Singh S, Renuse S, Vanderboom PM, Madugundu AK, Budhraja R, McAulay K, Grys TE, Rule AD, Alexander MP, O'Horo JC, Badley AD, Pandey A. Chavan S, et al. J Proteome Res. 2021 Jul 2;20(7):3404-3413. doi: 10.1021/acs.jproteome.1c00391. Epub 2021 Jun 2. J Proteome Res. 2021. PMID: 34077217 Free PMC article.
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL.
Temesgen Z, Burger CD, Baker J, Polk C, Libertin C, Kelley C, Marconi VC, Orenstein R, Durrant C, Chappell D, Ahmed O, Chappell G, Badley AD. Temesgen Z, et al. medRxiv [Preprint]. 2021 May 5:2021.05.01.21256470. doi: 10.1101/2021.05.01.21256470. medRxiv. 2021. PMID: 33972949 Free PMC article. Preprint.
A Blueprint to Control the SARS-CoV-2 Pandemic.
O'Horo JC, Williams AW, Badley AD. O'Horo JC, et al. Mayo Clin Proc. 2021 May;96(5):1128-1131. doi: 10.1016/j.mayocp.2021.03.013. Epub 2021 Mar 26. Mayo Clin Proc. 2021. PMID: 33958050 Free PMC article. No abstract available.
The long road to TRAIL therapy: a TRAILshort detour.
Chandrasekar AP, Maynes M, Badley AD. Chandrasekar AP, et al. Oncotarget. 2021 Mar 30;12(7):589-591. doi: 10.18632/oncotarget.27902. eCollection 2021 Mar 30. Oncotarget. 2021. PMID: 33868580 Free PMC article. No abstract available.
23 results